Navigation Links
Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011
Date:2/17/2011

EAST BRUNSWICK, N.J., Feb. 17, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today that its fourth quarter and year-end 2010 financial results will be released on Friday, February 25, 2011, at 7:00 a.m. Eastern Time. Following the announcement, John H. Johnson, Chief Executive Officer, and David Gionco, Group Vice President and Chief Financial Officer, will host an investment community conference call and webcast at 9:00 a.m. Eastern Time to review the Company's financial results and recent business developments.

To participate by telephone, please dial 888-357-3694 (Domestic) or 973-890-8276 (International). The conference identification number is 45733606. The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com. Please log on to Savient's website 15 minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 12:00 p.m. Eastern Time on Friday, February 25, 2011, through 11:59 p.m. Eastern Time on March 11, 2011 by dialing 800-642-1687 (Domestic) or 706-645-9291 (International) and entering conference ID number 45733606.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA™ (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. an
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Closes Sale of $230 Million in Convertible Senior Notes
2. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
3. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
4. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
5. Savient Pharmaceuticals Announces Search for CEO
6. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
7. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXAâ„¢ for Prescription and Reports Third Quarter 2010 Financial Results
8. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
9. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
10. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
11. Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... 15, 2011 Millennium HealthCare Inc. ... LLP, a Public Company Accounting Oversight Board (PCAOB) accounting ... KBL, LLP provides a combination of technology, ... businesses. Their professionals maintain an entrepreneurial spirit and a ...
... US, LLC ("Astellas") recently named Percival Barretto-Ko as ... a new position added to the company,s leadership ... Barretto-Ko will be responsible for corporate planning, business ... government affairs. "This realignment brings key ...
Cached Medicine Technology:Millennium HealthCare Inc. Engages KBL, LLP 2Astellas Expands Leadership Team With Senior Vice President of Corporate Strategy and Government Affairs 2
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley ... recognized in the 2015 Aster Awards national competition for a marketing communications campaign ... City and surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form ... been advanced, upgraded, made more effective and less intrusive and painful. Leading these ... Enlargement Center. Dr. Loria currently stands as the only doctor in the United ...
(Date:7/31/2015)... New York, NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The ... this photo op. , Glancing out of the window, he recalled that his equipment ... 215 Chrystie Street tower, he jumped out of bed. , The photo speaks ...
(Date:7/31/2015)... ... , ... Ticket Down is a reputable source of authentic USA vs. ... will face the Australia Women's National Team in two separate friendly contests. The ... and the second match will occur in Birmingham, Alabama at Legion Field. These ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in conjunction with their Victory Tour ... 5-2. Carli Lloyd from the USA team was awarded the Golden Ball as the ...
Breaking Medicine News(10 mins):Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... are calling on the Federal Government to fund a new ... ,Rotavirus puts 10,000 Australian children in hospital each year, ... at doctors' surgeries with symptoms of acute diarrhoea and vomiting. ... aged six to 32 weeks, is only available by private ...
... to be "alarmingly dismal" with over 180 million urban poor ... says an industry analysis. ,At least 300 additional ... up annually to cater to the needs of 215 million ... Chambers of Commerce and Industry of India (ASSOCHAM). ...
... information management device by Intel and Motion Computing, is no ... that it is starting to ship the device to hospitals ... with patients, do their jobs on the move while remaining ... an impressive array of features such as a camera, RFID ...
... tobacco industry memo from 1969. For half a century, the ... cancer. Now, with that effort long since failed, cigarette producers ... to manufacture doubt. ,"The tobacco industry is now ... everyone knew but no one had proof," said Robert N. ...
... its distinguishing shape? Shape may be formed by cell movement, ... of which react to// influences from the local environment. Initially, ... to develop into cardiac chambers. ,In a new ... Heidi Auman, Deborah Yelon, and colleagues found, by using transgenic ...
... experts Fred R. Volkmar, M.D., and Ami Klin are part ... an individual gene and a// region of a chromosome that ... are published online in Nature Genetics and also will be ... on the largest autism genome scan done to date. The ...
Cached Medicine News:Health News:Call for Rotavirus Vaccine Funding 2Health News:Urban Poor in Dire Need of Proper Healthcare: Report 2Health News:Tobacco Companies Obstructed Science 2Health News:Tobacco Companies Obstructed Science 3Health News:Autism Gene Identified by Yale and Global Consortium 2
... duty chair with electrical operation with ... and seat rotation with click stops ... heavy duty chair with electrical operation ... mm and seat rotation with click ...
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
Portable mini halogen light....
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Medicine Products: